The pharma company Teitur Trophics that targets neurodegenerative diseases has joined the BII Creation House program.
As part of the Creation House program, Teitur Trophics will have access to a global network of life science entrepreneurs and investors, labs and office space, business development and DKK 10M in funding during the coming 18 months.
For more information: